"Disease Models, Animal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Descriptor ID |
D004195
|
| MeSH Number(s) |
C22.232 E05.598.500 E05.599.395.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Disease Models, Animal".
Below are MeSH descriptors whose meaning is more specific than "Disease Models, Animal".
This graph shows the total number of publications written about "Disease Models, Animal" by people in this website by year, and whether "Disease Models, Animal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 5 | 5 |
| 1999 | 2 | 5 | 7 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 8 | 9 |
| 2002 | 4 | 11 | 15 |
| 2003 | 0 | 7 | 7 |
| 2004 | 2 | 7 | 9 |
| 2005 | 2 | 13 | 15 |
| 2006 | 4 | 13 | 17 |
| 2007 | 6 | 23 | 29 |
| 2008 | 1 | 29 | 30 |
| 2009 | 4 | 37 | 41 |
| 2010 | 2 | 38 | 40 |
| 2011 | 3 | 28 | 31 |
| 2012 | 3 | 35 | 38 |
| 2013 | 4 | 41 | 45 |
| 2014 | 2 | 58 | 60 |
| 2015 | 2 | 53 | 55 |
| 2016 | 6 | 45 | 51 |
| 2017 | 4 | 45 | 49 |
| 2018 | 9 | 54 | 63 |
| 2019 | 3 | 67 | 70 |
| 2020 | 5 | 59 | 64 |
| 2021 | 3 | 35 | 38 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 15 | 15 |
| 2024 | 11 | 14 | 25 |
| 2025 | 2 | 27 | 29 |
| 2026 | 2 | 7 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Models, Animal" by people in Profiles.
-
Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. Mol Cancer. 2026 Jul 08; 25(1).
-
Staphylococcus aureus pore-forming toxins differentially shape disease severity in experimental endophthalmitis. Infect Immun. 2026 Jul 14; 94(7):e0016826.
-
Polysaccharide-based self-assembled hemp seed oil nanoemulgel ameliorates skin inflammation in a psoriasis mouse model. Int J Biol Macromol. 2026 Aug; 372:153114.
-
Induction of Murine Models of Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy. Curr Protoc. 2026 Jun; 6(6):e70183.
-
Generation of the Early-Gestational Maternal Immune Activation Mouse Model to Assess Prenatal Inflammation on Neurodevelopment. J Vis Exp. 2026 03 24; (229).
-
Controlled release of bone morphogenetic protein-2 improves motor function after traumatic brain injury in a rat model. J Mater Chem B. 2026 Mar 11; 14(10):3129-3146.
-
S100A8/A9 inhibition reduces splenic myelopoiesis and improves outcomes after stroke. Front Immunol. 2026; 17:1768647.
-
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ. Breast Cancer Res. 2026 Jan 30; 28(1).
-
Resilient Calvarial Bone Marrow Supports Retinal Repair in Type 2 Diabetes. Adv Sci (Weinh). 2026 03; 13(13):e19680.
-
Astrocyte-specific deletion of ceruloplasmin exacerbates oxidative stress and demyelination in the spinal cord in a murine model of multiple sclerosis. Neurobiol Dis. 2026 Jan; 218:107249.